AstraZeneca Alderley Park Biobank Renewal

• Research type

  Research Tissue Bank

• IRAS ID

  225875

• Research summary

  AstraZeneca Alderley Park Biobank

• REC name

  North West - Haydock Research Ethics Committee

• REC reference

  17/NW/0207

• Date of REC Opinion

  20 Apr 2017

• REC opinion

  Favourable Opinion

• Data collection arrangements

  The Biobank receives surgical tissues, blood, plasma, serum, urine, other body fluids and cells; all surplus to diagnostic and therapeutic requirements or samples taken as part of an approved study/research protocol. Samples are from individuals with various disease types and normal biological samples may also be stored. A minimal proportion of material is sourced from the deceased.

  Samples and data are sourced from a variety of suppliers and collaborators according to researcher requirements. Suppliers must comply with AstraZeneca's policies and procedures, particularly with regards to the informed consent process.

• Research programme

  Human biological samples play a vital role in AstraZeneca Research and Development, helping to build a deeper understanding of human disease processes and their underlying mechanisms, and in developing new medicines by enabling earlier and better predictions about their effectiveness and safety.

• Storage license

  12109

• RTBTitle

  AstraZeneca Alderley Park Biobank

• Establishment organisation

  AstraZeneca

• Establishment organisation address

  Mereside, Alderley Park

  Macclesfield

  Cheshire

  SK10 4TG